Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06566612 · ClinicalTrials.gov registry record

Avoidance-driven Decision Making and Learning in Anorexia Nervosa and Bulimia Nervosa

A clinical trial of Anorexia Nervosa and Bulimia Nervosa, sponsored by University of California, San Diego.

Recruiting
Registry status
78
Enrollment target
1
Study location

NCT06566612: Recruiting study of Anorexia Nervosa and Bulimia Nervosa, sponsored by University of California, San Diego.

NCT06566612 is a study of Anorexia Nervosa and Bulimia Nervosa that is actively recruiting participants, run by University of California, San Diego. The registered enrollment target is 78 participants, below the 948-participant average among 43 other Anorexia Nervosa trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06566612, a study of Anorexia Nervosa and Bulimia Nervosa, is actively recruiting participants, sponsored by University of California, San Diego.

RECRUITING
Registry status
78 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to investigate areas of the brain responsible for avoidance learning in adults with eating disorders using brain imaging techniques, computer tasks, and self-report questionnaires and interviews. The investigators will study changes in brain activity using a procedure called functional magnetic resonance imaging (fMRI). This study will include 78 women with an eating disorder (26 with anorexia nervosa \[AN\], 26 with bulimia nervosa \[BN\]) and 26 healthy controls (HC) aged 18-39. Aim 1: Evaluate behavioral differences in active and passive avoidance learning in eating disorders and associations with symptoms. Aim 2: Evaluate whether corticostriatal and limbic-prefrontal fMRI BOLD response associated with avoidance learning differs in eating disorders relative to healthy controls and relates to symptoms. Aim 3: Evaluate whether functional connectivity of avoidance learning neural circuity differs in eating disorders relative to healthy controls.

Primary Outcome

Behavioral responses during a card game gambling task

Study Locations (1)

California

  • UCSD Eating Disorders Treatment and Research Program - La Jolla

Trial Details

FieldValue
Enrollment Target 78 participants
Start Date 2024-08-01
Est. Completion 2027-07-31
University of California, San Diego

775 total trials

What NCT06566612 shows while recruiting

NCT06566612 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 78 participants, a relatively small participant target, below the 948-participant average among 43 other Anorexia Nervosa trials with a reported enrollment target (92% lower).

The record links to 2 conditions, with Anorexia Nervosa appearing as the primary indexed condition, and to 0 interventions.

NCT06566612 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT06566612 about?

NCT06566612 is a clinical study titled "Avoidance-driven Decision Making and Learning in Anorexia Nervosa and Bulimia Nervosa". The purpose of this study is to investigate areas of the brain responsible for avoidance learning in adults with eating disorders using brain imaging techniques, computer tasks, and self-report questionnaires and interviews. The investigators will study changes in brain activity using a procedure ca...

What is the current status of trial NCT06566612?

This trial is currently recruiting. The enrollment target is 78 participants. The study started on 2024-08-01. Estimated completion is 2027-07-31.

What conditions does trial NCT06566612 study?

This clinical trial studies the following conditions: Anorexia Nervosa, Bulimia Nervosa.

Who is sponsoring clinical trial NCT06566612?

This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06566612 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Anorexia Nervosa

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06566612's enrollment target sits among peer trials

78 14th of 43 higher than 29 of 43 other Anorexia Nervosa trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Anorexia Nervosa trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02397668 · 78 participants · NA

    CorMatrix Cor TRICUSPID ECM Valve Replacement Study

  • NCT03321656 · 78 participants · Phase 2

    Impact of Envarsus XR® on Kidney Biopsy Subclinical Rejection and Blood Immunologic Profile

  • NCT03687814 · 78 participants · NA

    Low FODMAP Plus PEG 3350 for the Treatment of Patients with Irritable Bowel Syndrome-Constipation

  • NCT04018872 · 78 participants · Phase 2

    Evaluating the Effect of Itraconazole on Pathologic Complete Response Rates in Esophageal Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06566612, the US trial registry maintained by the National Library of Medicine. NCT06566612 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.